Page last updated: 2024-11-04

tegafur and Cardiovascular Diseases

tegafur has been researched along with Cardiovascular Diseases in 2 studies

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research Excerpts

ExcerptRelevanceReference
"The patient, who had unresectable colon cancer metastases to the liver and lung, was referred to us for chemotherapy from an affiliated hospital; he had no cardiac history."1.335-Fluorouracil cardiotoxicity induced by alpha-fluoro-beta-alanine. ( Hatakeyama, K; Muneoka, K; Shirai, Y; Wakai, T; Yokoyama, N, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Muneoka, K1
Shirai, Y1
Yokoyama, N1
Wakai, T1
Hatakeyama, K1
Jakobsen, A1
Mortensen, JP1
Bisgaard, C1
Lindebjerg, J1
Rafaelsen, SR1
Bendtsen, VO1

Trials

1 trial available for tegafur and Cardiovascular Diseases

ArticleYear
A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: a phase II trial.
    International journal of colorectal disease, 2008, Volume: 23, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cardiovascular

2008

Other Studies

1 other study available for tegafur and Cardiovascular Diseases

ArticleYear
5-Fluorouracil cardiotoxicity induced by alpha-fluoro-beta-alanine.
    International journal of clinical oncology, 2005, Volume: 10, Issue:6

    Topics: Aged; Antimetabolites, Antineoplastic; beta-Alanine; Cardiovascular Diseases; Colonic Neoplasms; Dru

2005